Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmaxis Ltd ( (AU:SNT) ) has issued an update.
Syntara Limited has announced a new issuance of 44,028,744 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) on February 20, 2025. This issuance is a part of previously announced transactions and reflects Syntara Limited’s strategic financial maneuvers to enhance its market presence and potentially fortify its capital structure, thus impacting its stakeholders and industry positioning.
More about Pharmaxis Ltd
YTD Price Performance: 7.50%
Average Trading Volume: 5,375,335
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$135.8M
For detailed information about SNT stock, go to TipRanks’ Stock Analysis page.